EMA Looks At Avastin, As Novartis/Roche Appeal Italian Competition Fines
This article was originally published in The Pink Sheet Daily
Executive Summary
With EMA deliberating about Avastin, Novartis and Roche have confirmed that they will appeal the €180.5 million fine imposed on them by Italy’s competition authority for anti-competitive behavior.